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Abstract
Background: Abnormalities of cell cycle regulators are common features in human cancers, and several of these 
factors are associated with the early development of gastric cancers. However, recent studies have shown that gastric 
cancer tumorigenesis was characterized by mucin expression. Thus, expression patterns of cell cycle-related proteins 
were investigated in the early phase of differentiated-type gastric cancers to ascertain any mechanistic relationships 
with mucin phenotypes.
Methods: Immunostaining for Cyclins D1, A, E, and p21, p27, p53 and β-catenin was used to examine impairments of 
the cell cycle in 190 gastric intramucosal differentiated-type cancers. Mucin phenotypes were determined by the 
expressions of MUC5AC, MUC6, MUC2 and CD10. A Ki-67 positive rate (PR) was also examined.
Results: Overexpressions of p53, cyclin D1 and cyclin A were significantly more frequent in a gastric phenotype than 
an intestinal phenotype. Cyclin A was overexpressed in a mixed phenotype compared with an intestinal phenotype, 
while p27 overexpression was more frequent in an intestinal phenotype than in a mixed phenotype. Reduction of p21 
was a common feature of the gastric intramucosal differentiated-type cancers examined.
Conclusions: Our results suggest that the levels of some cell cycle regulators appear to be associated with mucin 
phenotypes of early gastric differentiated-type cancers.
Background
Progression through the cell cycle and cellular prolifera-
tion are under the control of a series of cyclins and cyclin-
dependent kinase (cdk) complexes [1-3]. Accumulating
evidence shows that the progression of tumorigenesis fre-
quently involves abnormalities in the expressions of
cyclins and other cell-cycle related genes [1-3]. Abnor-
malities have been found for cyclins D1, A, E and their
co-operating partners, such as cyclin-dependent kinase
(cdk), that promote cell cycle progression [1,3]. Addition-
ally, these progressive factors can be inhibited by block-
ers, such as p21, p27 and p57, and another group of
inhibitor proteins, including p16, p15 and p18 [4-10]. The
uncontrolled proliferation that characterizes tumor cells
can be largely explained by the gain and/or loss of protein
functions that comprise the cell cycle. Regulation of these
cell cycle-related proteins is also governed by other fac-
tors, including p53 and β-catenin, and their alterations
also impair the cell cycle, resulting in uncontrolled prolif-
eration [11-15].
Of the above cell cycle-related proteins, key regulators
of progression through the G1 phase of the cell cycle are
cyclin D1 and cyclin E, p53, p21 and p27 [1,4,6,12]. Their
abnormal expressions have been thought to play pivotal
roles in the progression of tumorigenesis and have been
found to be disturbed in a number of human malignan-
cies. Cyclin A is also a member of the cyclin protein
superfamily that can be activated during the transition
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from the G1 to the S phase of the cell cycle. Abnormal
expressions of cyclin A are correlated with poor out-
comes in various human cancers [8,9]. In addition,
nuclear expression of β-catenin is implicated in gastroin-
testinal cancers [14,15]. β-catenin accumulates in the
nucleus due to impairments of the Wnt signal pathway,
and its nuclear expression promotes progression of the
cell cycle and cellular proliferation [14,15]. However, to
date, its activity has not been shown to affect the patho-
genesis of early differentiated-type gastric cancers.
Recent studies have shown that cellular mucin expres-
sions and tumor phenotypes are associated with the clin-
ico-pathological findings and tumorigenesis in
differentiated-type gastric cancers [16-19]. The mucin
phenotypes of tumors have been primarily classified into
3 types: gastric, intestinal and mixed phenotypes [16,17].
The gastric phenotype is characterized by poor out-
comes, distinct histological features and a specific sub-
type of genetic alterations, including microsatellite
instability (MSI) [17,18]. In contrast, the intestinal phe-
notype is a very well differentiated type, with low prolifer-
ative activity and a lack of MSI [17]. The expressions of
mucins by tumor cells define tumor characteristics in
gastric cancers [16-19]. Thus, it is important for the
understanding of early tumorigeneis of gastric cancers to
examine biological alterations according to these mucin
phenotypes [16-19].
Although a number of studies regarding the expres-
sions of cell cycle-related factors have been reported [3-
7], the associations of early differentiated-type gastric
cancers and their mucin phenotypes and alterations of
cell-cycle-related proteins are not fully understood. In the
present study, we examined abnormalities of cell cycle-
related proteins of the early phase of differentiated-type
gastric cancers based on mucin phenotypes.
Methods
Patients
Materials for this study were obtained from 190 patients
with primary early gastric cancers that were diagnosed at
the Division of Molecular Diagnostic Pathology, Depart-
ment of Pathology, Iwate Medical University, Morioka,
Japan. Informed consent was given in all patients that we
examined. In addition, our study was approved by our
ethics committee (title, molecular analysis of gastrointes-
tinal tumors and the surrounding mucosa; reference
number, H21-140, ethics committee of Iwate Medical
University). These tumors were consistent with intramu-
cosal differentiated-type cancers, and were obtained from
samples of endoscopic submucosal dissection (ESD). The
histological criteria used to make histological diagnoses
were based on our hospital criteria [16], which were mod-
ified from those of the Japanese Research Society for Gas-
tric Cancers [20], as discrepancies in histological
judgments exist between Japanese and Western patholo-
gists. Detailed clinico-pathological data (patient age, sex,
site of tumor, tumor size, macroscopic type and degree of
tumor differentiation) are shown in Additional file 1.
In this study, intramucosal differentiated-type cancers
were sub-classified into 3 groups according to the tumor
nuclear grade: low, intermediate or high. The tumor
grade was determined according to previously published
criteria [17]. In brief, low-grade cancer was diagnosed by
the presence of cells with enlarged, hyperchromatic
nuclei that were largely confined to the basal portions of
the cells, but that had more irregular and complex glands
than gastric adenomas. Tumors that contained cells hav-
ing an obvious loss of polarity, high nuclear irregularity,
enlarged nucleolus and hyperchromatin were classified as
high-grade cancers. The high grade cancers often showed
significant architectural atypia, such as high architectural
or glandular distortions. Intermediate findings between
low and high-grade cancers were recognized as interme-
diate cancers. However, the histological distinction
between gastric adenoma and low-grade cancer was
sometimes very difficult. The slides were independently
evaluated by 2 experienced pathologists (S. T. and N. S.);
in some cases in which the evaluations provided different
results, a consensus interpretation was reached after re-
examination.
Immunohistochemistry
Immediately after excision, specimens were fixed in 20%
neutral buffered formalin, embedded in paraffin wax, cut
into 3 μm paraffin sections and stained with haematoxy-
lin and eosin (HE) for routine light microscopy. For
immunohistochemical staining, additional 3 μm thick
sections were cut from paraffin-embedded tissue and
placed on poly-L-lysine-coated glass slides. In brief, sec-
tions were deparaffinized in xylene and dehydrated. For
the determination of mucin phenotypes, immunostaining
was done for MUC 2 (Ccp58, Novocastra Laboratories,
Newcastle, UK), CD10 (56C6, Novocastra Laboratories),
MUC 5AC (CLH2, Novocastra Laboratories) and MUC 6
(CLH5, Novocastra Laboratories, Newcastle, UK). In
addition, immunostaining was done for p53 (clone, DO7,
DAKO, Carpinteria, CA, USA), Ki-67 (MIB-1, Dako), p21
(SX118, Dako), p27 (SX53G8, Dako), cyclin D1 (SP4,
Nichirei Co., Tokyo), cyclin E (13A3, Novocastra Labora-
tories), cyclin A (6E6, Novocastra Laboratories) and β-
catenin (BD, Transduction Laboratories).
Immunohistochemistry used the DAKO Envision+ sys-
tem, consisting of dextran polymers conjugated with
horseradish peroxidase (DAKO), as previously described
[16,17]. The specimens were heated by microwave in cit-
rate buffer (pH 6.0) 3 times for 5 min each at 750W before
the reactions with antibodies (H2500, Microwave Proces-Sugai et al. BMC Gastroenterology 2010, 10:55
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sor, Bio Rad, USA), as previously described [16,17].
Hematoxylin was used as the counterstain.
Evaluation of mucin expression
In this study, gastric tumors were classified into 4 groups
according to their immunostaining patterns. A gastric
phenotype was defined as tumors having predominant
intracytoplasmic mucin of the gastric type, as determined
by immunostaining with human gastric mucin
(MUC5AC) and/or pyloric gland mucin (MUC6), but
with no MUC-2 positive cells. An intestinal phenotype
was indicated by a tumor showing MUC2-positive cells
and/or CD10 positive (along with a brush border). These
tumors were differentiated to small intestinal absorptive
cells. Intestinal phenotype tumors were sub-classified
into 2 groups: colonic type (positive for MUC 2 only) and
small intestinal type (positive for CD10). A mixed pheno-
type was defined as a tumor having immunostaining con-
sistent with gastric type (positive cells for MUC5AC and/
or pyloric gland mucin) as well as intestinal type mucin
(positive cells for CD10 and/or MUC2). Finally, tumors
without immunostaining for either gastric or intestinal
p h e n o t y p e s  w e r e  a s s i g n e d  t o  a n  " u n c l a s s i f i e d "  t y p e .
Immunopositive results for > 5% of the tumor cells were
regarded as positive, and immunopositive results for < 5%
as negative, in accordance with previous reports
[16,17,21].
Measuring the Ki-67 positive rate (PR)
Random areas from each sample were selected in which
to count Ki-67 positive nuclei. The Ki-67 positive rate
was calculated as the percentage of Ki-67 positive tumor
cell nuclei determined in 10 high-power fields (HPF, ×
400), which was determined after counting at least 500
tumor cells per tumor sample. Tumor proliferative activ-
ity was classified into 2 groups: high and low. The prolif-
erative activity was determined according to our criteria
[16,17]. In brief, PR of the tissue was measured in both
the tumor tissue and its surrounding non-neoplastic tis-
sue. High proliferation was considered if PR was higher in
the tumor tissue than in the non-neoplastic tissue. Low
proliferation was judged if PR was lower in the tumor tis-
sue than in the non-neoplastic tissue.
Immunohistochemical assessment of cell cycle-related 
proteins
The proportion of tumor cells per section was assessed by
eye and allocated a score as summarized in Additional file
2A. A total of 500 cells were counted in random fields
from representative areas of the lesion. For all markers,
only nuclear staining was considered positive. The stain-
ing intensity was estimated on a 5-point scale (0 to 6+)
and a score was allocated according to the intensity
(Additional file 2B). The staining index was a simple mul-
tiplicative product of the cellularity and staining scores.
Next, high expression for tumor cells was recorded if the
staining index was higher in the tumor cells than in its
surrounding non-neoplastic tissue. In contrast, low
expression for tumor cells was recorded if the staining
index was lower or equal in the tumor cells than in the
non-neoplastic tissue. For example, a representative fig-
ure is shown in Figure 1. The original criteria were
described previously [22], and the present criteria were
used with minor modifications. Two sections were
stained and values were based on the mean of the 2 indi-
vidual results.
Statistical analysis
Results are given as median or mean values. Statistical
analysis used the Tamhane Test for comparisons among 3
groups and chi-square tests for comparisons between 2
groups. Statistical significance was established at the p <
0.05 level.
Results
Clinico-pathological characteristics
As shown in Additional file 3, of the 190 gastric intramu-
cosal differentiated-type cancers, 23 (12.1%) were of the
gastric phenotype, 85 (44.7%) were the intestinal pheno-
type and 79 (41.6%) were classified as mixed phenotypes.
Only 3 (1.6%) tumors were of the unclassified type. Clin-
ico-pathological findings based on the mucin phenotypes
are also listed in Additional file 3. There were no signifi-
cant differences for age, tumor size, location, microscopic
type or histological type between the 3 phenotypes. How-
ever, for the gastric and mixed phenotypes, the inci-
dences of high grade tumors were significantly higher for
the gastric and mixed phenotypes than the intestinal phe-
notype (p < 0.01 and p < 0.05, respectively). In addition,
the male/female ratio for the mixed phenotype was ower
than for the other types (p < 0.05).
In the present study, gastric phenotypes were classified
into 3 sub-phenotypes: MUC5AC (+)/MUC6 (+),
Figure 1 Example of gastric intramucosal differentiated-type 
cancer. Whereas the index score for cyclin D1 expression is 16 in the 
gastric cancer mucosa (b), the score is 4 in its surrounding non-neo-
plastic mucosa (a). The tumor that is shown in figure 1b is regarded as 
well differentiated adenocarcinoma by Japanese pathologists, al-
though this tumor is considered gastric adenoma or dysplasia by West-
ern pathologists.Sugai et al. BMC Gastroenterology 2010, 10:55
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MUC5AC (+)/MUC6 (-) and MUC5AC (-)/MUC6 (+).
Fifteen (65.2%) had the MUC5AC (+)/MUC6 (+) pattern,
5 (21.7%) had the MUC5AC (+)/MUC6 (-) pattern and 3
(13.1%) were subclassified as the MUC5AC (-)/MUC6 (+)
pattern. Among the 3 gastric sub-phenotypes, no clinico-
pathological differences were found. In contrast, intesti-
nal phenotypes were sub-divided into small intestinal (N
= 67) and colonic (N = 18) phenotypes. There were no
significant differences between them for age, tumor size,
location, macroscopic type or histological type.
Expressions of cell cycle-related proteins by mucin 
phenotypes
No p53 overexpression was found in any surrounding
non-neoplastic mucosa. Overexpression of p53 was
observed in 33 of 190 cases that we examined (17.4%),
and was more frequently seen in the gastric phenotype
(10/23, 43.5%) compared with the other 2 types (intesti-
nal phenotype, 13/85, 15.3% and mixed phenotype, 9/79,
11.4%). Although the difference between the gastric and
intestinal phenotypes did not reach statistical signifi-
cance (p = 0.054), the gastric and mixed phenotypes did
show a significant difference (p < 0.05). In addition, no
p53 overexpression was found in low-grade cancers (0/
26). In contrast, p53 was overexpressed in 11 of 103 inter-
mediate-grade cancers (10.7%) and 22 of 61 high-grade
cancers (36.1%). Significant differences between high-
grade cancer and low-grade or intermediate-grade can-
cers were found (p < 0.01).
p21 was primarily expressed in the superficial epithe-
lium of the intestinal metaplastic gland and the gastric
foveolar epithelium. The frequency of reduced p21
expression was 59 of 190 tumors (31.1%). Reduced p21
expression was commonly observed in the gastric, intesti-
nal and mixed phenotypes. There was no significant dif-
ference for reduced p21 expressions between the 3
phenotypes.
Expression of p27 was confined to the superficial epi-
thelium and the base of the intestinal metaplastic gland.
The frequency of reduced p27 expression was very low in
the gastric cancers that we examined (12/190, 6.3%). In
contrast, the frequency for p27 overexpression was
observed in 53 of 190 tumors (27.9%). The frequency of p
27 overexpression was higher in the intestinal phenotype
(31/85, 36.5%) than in the gastric (6/23, 26.1%) and mixed
phenotypes (16/79, 20.2%). However, these differences
were not significant.
Cyclin D1 was expressed at the lower half of the intesti-
nal metaplastic gland. In the gastric cancers examined, 27
of 190 cases (14.2%) showed overexpressed Cyclin D1.
Cyclin D1 was overexpressed in the gastric phenotype for
7 of 23 cases (30.4%). By comparison, overexpression of
cyclin D1 was found in 11.8% (10/85) and 12.7% (10/79)
of the intestinal and mixed phenotypes, respectively. No
significant difference was found between the gastric phe-
notype and the other types.
Expression of cyclin A was primarily confined to the
lower half of the intestinal metaplastic gland. Positive
staining for cyclin A was detected in 42.1% (80/190). The
frequency of cyclin A overexpression was higher in the
gastric phenotype (16/23, 69.6%) than in the intestinal
phenotype (25/85, 29.4%; p < 0.01). However, no signifi-
cant difference was found between the gastric and mixed
phenotypes (39/79, 49.4%).
Non-neoplastic glands were mostly negative for cyclin
E. In the gastric cancers examined, the frequency of
cyclin E overexpression was very low. No significant dif-
ference between the 3 mucin phenotypes was seen.
In this study, only the nuclear expression for β-catenin
w a s  r e g a r d e d  a s  p o s i t i v e .  N o  n u c l e a r  e x p r e s s i o n  o f  β -
catenin was observed in the surrounding non-neoplastic
mucosa, except for pyloric glands. Most pyloric glands
expressed nuclear β-catenin. Nuclear β-catenin expres-
sion was found in 80 of 190 tumors (36.8%). Although the
intestinal phenotype (44/85, 51.8%) showed the highest
frequency for nuclear β-catenin among the 3 phenotypes,
the difference was not significant.
A high proliferation rate of tumor cells was shown in
more than 30% Ki-67 PR in most of the gastric cancers
that we examined. According to our criteria, high prolif-
eration was found in 101 of 190 tumors (53.2%). High
proliferation of tumor cells was more frequently observed
in the gastric and mixed phenotypes compared with the
intestinal phenotype (p < 0.01 and p < 0.05). We have
summarized these results for cell cycle-related proteins
based on mucin phenotype in Figure 2. In addition, a rep-
resentative example is shown in Figure 3.
Discussion
In spite of a decreasing trend in incidence, gastric cancer
remains an important medical problem throughout the
world, and it is the most common neoplasm in Japan.
Intramucosal cancer is defined as a tumor at the most
early stage of gastric cancer. It is essential to examine
intramucosal cancer for evaluating the pathogenesis of
gastric cancer. It is widely accepted that a cancerous cell
arises due to abnormalities of cell cycle regulation, which
is comprised of several cell cycle-related proteins, such as
cyclins, cyclin dependent kinase inhibitor, p53 and β-
catenin. In addition, recent studies have shown that dis-
tinct clinico-pathological findings for gastric cancer are
characterized by mucin expressions. We studied abnor-
mal expressions of cell cycle-related proteins that pro-
mote gastric carcinogenesis based on mucin phenotypes
in gastric intramucosal differentiated-type cancers.
In the present study, immunohistochemistry was used
to investigate the expression levels of cell cycle-related
proteins. Immunopositivity for cell cycle-related proteinsSugai et al. BMC Gastroenterology 2010, 10:55
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of tumor tissue was determined by comparing the levels
between tumor tissue and its surrounding non-neoplastic
tissue. According to these criteria, the level of immunop-
ositivity of tumor tissue may differ for each case. How-
ever, separating the parameters within these cancers into
"low" and "high" categories based on comparisons of
these factors with non-neoplastic tissue may be an
unconventional method. The "non-neoplastic" tissue
includes gastritis (chronic or chronic active) and/or intes-
tinal metaplasia; the parameters in these various inflam-
matory or metaplastic tissues could vary considerably. It
may be more meaningful to use an absolute rate (i.e., the
actual %), rather than this internal relative value. How-
ever, we consider that this immunohistochemical crite-
rion is important for finding the potential activities of cell
cycle-related proteins at an early stage of gastric differen-
tiated-type cancers, given that the non-neoplastic tissue
surrounding tumor tissue is closely associated with
tumor development.
It has been believed among pathologists that the gastric
phenotype of gastric cancer shows low-grade atypia in
gastric intramucosal differentiated-type cancers (19).
However, in the present study, in the gastric intramucosal
differentiated-type cancers that we examined, the gastric
phenotype showed high-grade atypia. Although the rea-
son remains unknown, one possible reason is that a gas-
tric phenotype showing low-grade atypia, which
resembles gastric foveolar epithelium histologically, may
have been included in previous studies. In the present
study, only one such tumor was observed. In addition,
these differences could be due to the number of samples
or to ethnic or etiologic factors. It is well known that p53
overexpression is correlated with tumor grade. In the
present study, we suggest that it is reasonable to show a
Figure 2 Frequencies of cell cycle-related protein expressions in gastric, intestinal and mixed phenotypes. Gastric phenotype cancers are 
characterized by p53 and cyclin A overexpressions. Although the frequency of p27 overexpression between the intestinal phenotype and other phe-
notypes did not reach statistical difference, this may be characteristic of the intestinal phenotype. Reduction of p21 and accumulation of β-catenin 
are commonly observed in the 3 phenotypes. Ki-67 positive rate is higher in the gastric phenotype or mixed phenotype than in the intestinal pheno-
type. Statistical comparisons used Tamhane tests for all 3 phenotypes.
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high frequency of p53 overexpression for the gastric phe-
notype when compared with other phenotypes.
In this study, p53 overexpression was more frequently
found in the gastric phenotype than in the intestinal or
mixed phenotypes. This finding suggests that p53 overex-
pression plays an essential role, at least in the early devel-
opment of gastric phenotype cancer, although previous
studies have shown progressive increases in p53 overex-
pression in gastric cancers from the early to advanced
stages [12].
In this study, reduced p21 expression was observed in
approximately 30% of the 3 mucin phenotypes. Previous
studies have shown that low expression of p21 is corre-
lated with patient prognosis in gastric cancer [5,6]. How-
ever, little is known regarding p21 expression by gastric
cancers based on mucin phenotypes. In addition, any
association of p21 expression with tumor stage (tumor
depth) remains unknown. Our finding suggests that
reduced p21 expression plays a common role in the early
development of the 3 mucin phenotypes of gastric differ-
entiated-type cancers. However, a previous study sug-
gested that a progressive decrease of p21 expression
occurred in an advanced phase of gastric differentiated-
type cancer from the early phase [6]. p21 expression also
correlated with the expressions of other cell cycle-related
proteins, such as p27 and Ki-67, possibly through a p53-
dependent pathway [1,5,6]. It has been hypothesized that
p21 co-operates with p53 and, as a result, the cell cycle is
controlled through a p53-dependent pathway [1,5]. Fur-
thermore, it is believed that p21 is also inhibited by co-
operation with p27 [1,5]. In the present study, however,
we found neither a correlation of p21 reduction with p27
reduction nor an inverse correlation of p27 reduction
with p53 overexpression (data not shown). We suggest
that a different pathway exists for controlling the cell
cycle in human gastric cancers.
It is well known that p27 is a prototypical tumor sup-
pressor gene [1-3]. However, a recent study has shown
that, whereas in some cases, p27 inhibits the cell cycle, in
other cases it promotes progression to the next phase of
the cell cycle [23]. It has been reported that either a loss
or a low expression of p27 is correlated with tumor pro-
gression or patient prognosis [24,25]. In contrast to other
studies, we showed that low expression (reduction) of p27
had a very low frequency in our series of gastric cancers.
According to the present findings, reduced p27 expres-
sion plays a minor role in the development of differenti-
ated type gastric cancers.
In contrast, overexpression of p27 was frequently found
in the intestinal phenotype compared with the other 2
phenotypes, although the difference between them did
not reach a statistically significant level. Whether or not
this overexpression of p27 is associated with cell cycle
inhibition or cell cycle progression is not known,
although several explanations are suggested. First is that
p27 that is overexpressed for suppression of cell cycle
progression in tumor cells results from a negative feed-
back mechanism. Conversely, a second explanation is that
overexpression of p27 is positively associated with the
progression of the cell cycle for tumor cells; that is, p27
acts as an oncogenic factor [23]. In addition, a recent
study has shown that expression of p27 is regulated by
expression of Skp2, which is a ubiquitin ligase subunit of
p27 [26]. According to this report, expression of p27 was
inversely correlated with Skp2 expression.
Cyclin D1 overexpression only showed a low frequency
in the early stage of gastric differentiated type cancers
(27/190, 14.2%). However, although the differences did
not reach a significant level, the frequency of cyclin D1
overexpression was higher in the gastric phenotype than
in the intestinal and mixed phenotypes. Cyclin D1 was
previously studied in several series of gastric cancers,
with a reported frequency of 20~56% of overexpression
being reported [27-29], different from our results. As a
possible reason for these differences of cyclin D1 overex-
pression, although early differentiated-type cancers,
except for gastric phenotype, do not require an increase
of cyclin D1, once the tumor has developed, the tumor
cells need a high level of cyclin D1 for tumor progression.
This suggests that cyclin D1 overexpression is correlated
with patient prognosis in gastric cancers [28].
Overexpression of cyclin A was also more prevalent in
the gastric and mixed phenotypes compared with the
intestinal phenotype. This suggests that overexpression of
cyclin A plays a major role in tumorigenesis of gastric and
mixed phenotypes. Thus, in gastric cancers, acquisition
Figure 3 A representative example of intestinal intramucosal dif-
ferentiated-type cancer of the gastric phenotype. a. Low power 
view of tumor tissue. b. High power view of tumor tissue. c. p53 over-
expression was seen. d. p21 was reduced. e. p27 was overexpressed. f. 
Overexpression of cyclin A. g. Low expression of cyclin D1. h. Only 
Muc2 was expressed in this tumor, suggesting intestinal phenotype.Sugai et al. BMC Gastroenterology 2010, 10:55
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of gastric mucin expression may be associated with cyclin
A overexpression, which then results in high tumor pro-
liferation. In addition, cyclin A was closely associated
with patient prognosis or tumor aggressiveness [8,9]. This
may indicate that cyclin A overexpression is related to
both tumor development and progression in approxi-
mately half of differentiated-type gastric cancers.
In the present study, cyclin E overexpression showed
low frequencies in the 3 phenotypes. In contrast, previ-
ous studies have shown that cyclin E overexpression was
correlated with poor outcome [4,10], although contrast-
ing results have been suggested [30]. The present results
indicate that cyclin E overexpression plays no essential
role in the early tumorigenesis of differentiated-type gas-
tric cancers. In addition, overexpression of cyclin E may
primarily promote the progression of gastric cancers.
These findings suggest that the high proliferation of the
gastric phenotype may be characterized by the overex-
pression of cyclin D1 and/or cyclin A, and that the mixed
phenotype is associated with cyclin A overexpression.
It is well known that β-catenin expression upregulates
the cell cycle and plays a central role in the Wnt signal
transduction pathway [14,15]. In the present study, it is
interesting to note that β-catenin expression was com-
monly observed in the early differentiated-type gastric
cancers that we examined. It is already accepted that β-
catenin expression is critical for colonic adenoma devel-
opment [31,32]. The present results and previous studies
regarding colorectal adenoma indicate that β-catenin
expression may be a common alteration in the early
development of gastrointestinal tumors [31]. This could
be explained by the findings that, in gastric cancers, gene
promoters associated with the Wnt signal pathway are
highly methylated [32-34], which results in the nuclear
accumulation of β-catenin expression.
Conclusions
In summary, we propose that the cellular mucin pheno-
types of intramucosal differentiated-type adenocarcino-
mas of the stomach are dependent on distinct cell cycle-
related alterations, and that the clinico-pathological find-
ings result from different pathways based on mucin
expression: gastric, intestinal and mixed phenotypes. Fig-
ure 4 illustrates a novel carcinogenesis model for intra-
mucosal differentiated-type adenocarcinomas that relies
on their mucin phenotypes. Based on abnormalities of
cell cycle-related proteins, overexpressions of p53 and
cyclin A characterize gastric phenotype cancers, whereas
overexpression of p27 may be associated with the devel-
opment of intestinal phenotype cancers. In contrast,
mixed-phenotype cancers are characterized by cyclin A
overexpression. In addition, mucin phenotypes appear to
be characterized by nuclear grade and cell proliferative
activity. Three of 190 tumors were of the unclassified
type, and this tumor molecular characteristic is not iden-
tified. Finally, little is known regarding the distinct molec-
Figure 4 A new hypothesis for tumorigenesis of gastric intramucosal differentiated-type cancer as defined by the mucin phenotype.
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￿Cyclin A  
￿High proliferative 
activity
￿Nuclear grade high
Mixed phenotype
Intestinal phenotype
￿p27  
￿Cyclin A  
￿Low proliferative 
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￿Cyclin A  
￿High proliferative activity
￿p21  
￿  catenin (+)
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ular alterations that are involved in the pathogenesis of
gastric cancer. Further studies will be necessary to
address this question.
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